Catalyst Event
Sanofi (SNY) · Other
From KEDI Nvidia Fixed Tech100 Index (KNVDT100)
3/18/2026, 12:00:00 AM
The US FDA granted Breakthrough Therapy designation for venglustat on March 18, 2026. This is expected to have a medium impact as it accelerates the regulatory path for a key pipeline candidate.
Korean Translation
2026년 3월 18일 미국 FDA가 벤글루스타트를 혁신치료제로 지정함. 이는 주요 파이프라인 후보의 규제 절차를 가속화하여 중간 정도의 영향을 미칠 것으로 예상됨.
Related Recent Events
Meta Platforms Inc (META) · Other
Meta will officially shut down VR access to its social platform Horizon Worlds on June 15, 2026, as part of a strategic shift away from its initial metaverse vision. Low importance as this strategic shift is estimated to have >=1% price impact scheduled.
6/15/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Q1 2026 earnings release, which is estimated to have a medium impact due to typical price volatility surrounding financial reports, is scheduled.
5/14/2026, 12:00:00 AM
Biogen Inc (BIIB) · Earnings Release
Q1 2026 earnings release (Low impact estimated as routine earnings releases typically see at least 1% volatility) scheduled.
5/6/2026, 12:00:00 AM
Linde Plc (LIN) · Earnings Release
First-quarter 2026 earnings release is scheduled.
4/30/2026, 12:00:00 AM
Amazon.com Inc (AMZN) · Earnings Release
Amazon's Q1 2026 earnings release is scheduled. The company guided for net sales between $173.5 billion and $178.5 billion. Medium importance is estimated as earnings reports typically drive significant market volatility.
4/29/2026, 12:00:00 AM
Western Digital Corp (WDC) · Earnings Release
Western Digital is scheduled to report its Q3 2026 financial results on 2026-04-29, with analysts forecasting an EPS of approximately $2.30. A medium impact is estimated as quarterly results typically drive significant price movement, so the release is expected.
4/29/2026, 12:00:00 AM